Search Ontology:
ChEBI
3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
- Term ID
- CHEBI:233704
- Synonyms
-
- 3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
- Definition
- An amino trisaccharide that consists of 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronic acid, 3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranose, and 3-aminopropyl 2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside residues linked sequentially (1->4) and (1->3). It is a derivative of the trisaccharide repeating unit of Pseudomonas aeruginosa serotype O51 O-antigen that contains an amino propyl linker at the reducing end.
- References
- Ontology
- ChEBI ( EBI )
- is a type of
-
Show first 5 Terms
Phenotype
Phenotype resulting from 3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
Phenotype where environments contain 3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
Phenotype modified by environments containing 3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
Phenotype affecting 3-aminopropyl 2-acetamido-2,3-dideoxy-3-{[(3R)-3-hydroxybutanoyl]amino}-beta-D-glucopyranuronosyl-(1->4)-3-O-acetyl-2,6-dideoxy-2-(ethanimidoylamino)-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-glucopyranoside
Human Disease Model